| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024726196 |
| P356 | DOI | 10.1007/S10620-005-1595-Z |
| P698 | PubMed publication ID | 15745085 |
| P2093 | author name string | Peter Layer | |
| Jutta Keller | |||
| Ulrich Rosien | |||
| Keihan Ahmadi-Simab | |||
| Christiane Fibbe | |||
| Jan C Mueller-Wolf | |||
| P2860 | cites work | Neuronal anomalies and normal muscle morphology at the hypomotile ileocecocolonic region of patients affected by idiopathic chronic constipation | Q30783265 |
| Role of NO in pyloric, antral, and duodenal motility and its interaction with other inhibitory mediators | Q36730281 | ||
| Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide | Q36762280 | ||
| The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine | Q37045047 | ||
| Review article: gastroduodenal bicarbonate secretion. | Q40598934 | ||
| Improved infusion system for intraluminal esophageal manometry | Q40772703 | ||
| PYY inhibition of VIP-stimulated ion transport in the rabbit distal ileum | Q41003952 | ||
| Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide | Q41816681 | ||
| Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands | Q41920241 | ||
| Response of the human intestine to high volume infusion | Q43213676 | ||
| Effects of vasoactive intestinal peptide and pancreatic polypeptide on small bowel propulsion in the rat. | Q43685348 | ||
| Diabetes mellitus is associated with a decrease in vasoactive intestinal polypeptide content of gastrointestinal tract of rat. | Q43907171 | ||
| The effects of VIP on intestinal motility: study on ex vivo perfused isolated canine jejunal loops | Q43910015 | ||
| Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea | Q44125767 | ||
| 5-HT4 receptor agonists and delta-opioid receptor antagonists act synergistically to stimulate colonic propulsion. | Q44350561 | ||
| Preliminary report: role of peptide YY in defence against diarrhoea | Q44609144 | ||
| Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique | Q44715947 | ||
| Effect of Vasoactive Intestinal Peptide on Duodenal Motility in the Isolated Perfused Porcine Pancreaticoduodenal Block | Q44735533 | ||
| Enteric GABA: mode of action and role in the regulation of the peristaltic reflex | Q44907852 | ||
| Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis | Q45093806 | ||
| Regulation of colonic propulsion by enteric excitatory and inhibitory neurotransmitters | Q45100028 | ||
| 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine | Q45112735 | ||
| Effect of somatostatin-14 on duodenal mucosal bicarbonate secretion in guinea pigs | Q46895105 | ||
| Serum nitrates and vasoactive intestinal peptide in patients with gastroesophageal reflux disease | Q46974984 | ||
| Circadian pancreatic enzyme pattern and relationship between secretory and motor activity in fasting humans | Q48655666 | ||
| Circadian coupling between pancreatic secretion and intestinal motility in humans | Q48704817 | ||
| Motor activity of vascularly perfused rat duodenum. 2. Effects of VIP, PACAP27 and PACAP38. | Q51457124 | ||
| Intraduodenal neuropeptide levels, but not plasma levels, vary in a cyclic fashion with the migrating motor complex. | Q51566203 | ||
| Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. | Q51598634 | ||
| Vasoactive intestinal peptide suppresses migrating myoelectric complex of rat small intestine independent of nitric oxide. | Q52534337 | ||
| Guanylin-, heat-stable enterotoxin of Escherichia coli- and vasoactive intestinal peptide-induced water and ion secretion in the rat intestine in vivo | Q54564147 | ||
| Cholinergic stimulation and nonadrenergic, noncholinergic relaxation of human colonic circular muscle in idiopathic chronic constipation | Q58229778 | ||
| Effect of 17-norleucine-VIP on gastroduodenal motility relative to serum VIP concentration and blockade of NOS | Q58449086 | ||
| Responses of porcine gastric and duodenal smooth muscle to VIP | Q67707530 | ||
| Interaction between prostanoids, NO, and VIP in modulation of duodenal alkaline secretion and motility | Q71738085 | ||
| Nitrergic inhibition of migrating myoelectric complex in the rat is mediated by vasoactive intestinal peptide | Q71873305 | ||
| Influence of the L-arginine-nitric oxide pathway on vasoactive intestinal polypeptide release and motility in the rat stomach in vitro | Q71876404 | ||
| Decreased substance P levels in rectal biopsies from patients with slow transit constipation | Q71939208 | ||
| Effect of vasoactive intestinal polypeptide on porcine gastrointestinal electrical activity | Q72120099 | ||
| Neural modulation of the antisecretory effect of peptide YY in the rat jejunum | Q73734515 | ||
| Neuropeptides in idiopathic chronic constipation (slow transit constipation) | Q73825811 | ||
| Rat gastroduodenal motility in vivo: interaction of GABA and VIP in control of spontaneous relaxations | Q77551251 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 276-282 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Do elevated plasma vasoactive intestinal polypeptide (VIP) levels cause small intestinal motor disturbances in humans? | |
| P478 | volume | 50 |
| Q47645343 | Comparative effect of electroacupuncture and moxibustion on the expression of substance P and vasoactive intestinal peptide in patients with irritable bowel syndrome |
| Q41920965 | Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis |
Search more.